Your Location: Set Your Location
See services nearest you.
Essentia Health Menu
Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
Back to Results
A Phase 3, Multi-center, Open-Label, Safety Study of Oral Edaravone Administered over 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS). The main purpose of this Research Study is to test whether an experimental drug called edaravone is safe and well tolerated in patients with your illness.
View this clinical trail on ClinicalTrials.gov.
Essentia Health East
For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.
Last Updated: 02/18/2020